These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9631919)

  • 1. An audit of therapeutic drug monitoring service provision by laboratories participating in an external quality assessment scheme.
    Thomson AH; Watson ID; Wilson JF; Sweeney G; Dawkins CE; Smith BL; Williams J; Capps NE; Toseland PA
    Ther Drug Monit; 1998 Jun; 20(3):248-52. PubMed ID: 9631919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison by external quality assessment of performance of analytical systems for measurement of therapeutic drugs in serum.
    Tsanaclis LM; Wilson JF
    Ther Drug Monit; 1997 Aug; 19(4):420-6. PubMed ID: 9263383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit of therapeutic drug monitoring of anticonvulsants.
    Sharpe PC; Morrow J; Trimble ER
    Ulster Med J; 1995 Oct; 64(2):151-6. PubMed ID: 8533181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The availability of toxicological analyses for poisoned patients in Ireland.
    Cassidy N; Herbert JX; Tracey JA
    Clin Toxicol (Phila); 2010 May; 48(4):373-9. PubMed ID: 20507249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme.
    Delattre IK; Van de Walle P; Van Campenhout C; Neels H; Verstraete AG; Wallemacq P
    Clin Biochem; 2015 Jun; 48(9):617-21. PubMed ID: 25818475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK accident and emergency departments and emergency contraception: what do they think and do?
    Gbolade BA; Elstein M; Yates D
    J Accid Emerg Med; 1999 Jan; 16(1):35-8. PubMed ID: 9918285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 1978 College of American Pathologists Therapeutic Drug Monitoring Interlaboratory Survey Program.
    Juel R
    Am J Clin Pathol; 1979 Aug; 72(2 Suppl):306-19. PubMed ID: 474507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire.
    Tobin CM; Darville JM; Thomson AH; Sweeney G; Wilson JF; MacGowan AP; White LO
    J Antimicrob Chemother; 2002 Nov; 50(5):713-8. PubMed ID: 12407128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring--the need for audit?
    Brodie MJ; McIntosh ME; Hallworth M
    Scott Med J; 1985 Apr; 30(2):75-82. PubMed ID: 3892678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision and accuracy of the measurement of antiepileptic drugs in South Africa.
    Chetty M; Wilson JF
    Ther Drug Monit; 1999 Apr; 21(2):215-8. PubMed ID: 10217342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate digoxin monitoring.
    Copeland RJ; Thorpe H; Kay EA
    J Clin Pharm Ther; 1992 Jun; 17(3):173-4. PubMed ID: 1639878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. I: Anticonvulsant drugs and theophylline. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
    Ther Drug Monit; 1991 Mar; 13(2):131-9. PubMed ID: 2053120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program.
    Burger D; Teulen M; Eerland J; Harteveld A; Aarnoutse R; Touw D
    Ther Drug Monit; 2011 Apr; 33(2):239-43. PubMed ID: 21383652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring.
    Shipkova M; Petrova DT; Rosler AE; Orth M; Engelmayer J; Wieland E; Brandhorst G; Oellerich M
    Ther Drug Monit; 2014 Aug; 36(4):433-41. PubMed ID: 24646729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
    Ther Drug Monit; 1991 Mar; 13(2):140-5. PubMed ID: 2053121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of psychotropic drugs in China: a nationwide survey.
    Guo W; Guo GX; Sun C; Zhang J; Rong Z; He J; Sun ZL; Yan F; Tang YL; Wang CY; Li WB
    Ther Drug Monit; 2013 Dec; 35(6):816-22. PubMed ID: 24263641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of requests for serum digoxin concentrations: experience from an Australian regional health service.
    Ellington C; Grgurinovich N; Miners JO; Mangoni AA
    Br J Clin Pharmacol; 2007 May; 63(5):623-7. PubMed ID: 17073890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian cyclosporin therapeutic monitoring method survey: 1993.
    Morris RG
    Ther Drug Monit; 1994 Dec; 16(6):564-9. PubMed ID: 7878695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The United Kingdom national microbiological quality assessment scheme.
    Snell JJ; De Mello JV; Gardner PS
    J Clin Pathol; 1982 Jan; 35(1):82-93. PubMed ID: 7061722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.